These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 26585390)

  • 21. Selective protein synthesis by ribosomes with a drug-obstructed exit tunnel.
    Kannan K; Vázquez-Laslop N; Mankin AS
    Cell; 2012 Oct; 151(3):508-20. PubMed ID: 23101624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of bacterial ribosome assembly: a suitable drug target?
    Maguire BA
    Microbiol Mol Biol Rev; 2009 Mar; 73(1):22-35. PubMed ID: 19258531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bacterial fatty acid metabolism in modern antibiotic discovery.
    Yao J; Rock CO
    Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Nov; 1862(11):1300-1309. PubMed ID: 27668701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of a Structurally Unique Small Molecule that Inhibits Protein Synthesis.
    Thakral D; Tae HS
    Yale J Biol Med; 2017 Mar; 90(1):35-43. PubMed ID: 28356892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Superiority of 11,12 carbonate macrolide antibiotics as inhibitors of translation and 50S ribosomal subunit formation in Staphylococcus aureus cells.
    Champney WS; Tober CL
    Curr Microbiol; 1999 Jun; 38(6):342-8. PubMed ID: 10341075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two nucleotide substitutions in the A-site of yeast 18S rRNA affect translation and differentiate the interaction of ribosomes with aminoglycoside antibiotics.
    Tselika S; Konstantinidis TC; Synetos D
    Biochimie; 2008 Jun; 90(6):908-17. PubMed ID: 18331849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Engineering the rRNA decoding site of eukaryotic cytosolic ribosomes in bacteria.
    Hobbie SN; Kalapala SK; Akshay S; Bruell C; Schmidt S; Dabow S; Vasella A; Sander P; Böttger EC
    Nucleic Acids Res; 2007; 35(18):6086-93. PubMed ID: 17766247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Importance of the 6'-hydroxy group and its configuration for apramycin activity.
    Mandhapati AR; Shcherbakov D; Duscha S; Vasella A; Böttger EC; Crich D
    ChemMedChem; 2014 Sep; 9(9):2074-83. PubMed ID: 25045149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibiotics in development targeting protein synthesis.
    Sutcliffe JA
    Ann N Y Acad Sci; 2011 Dec; 1241():122-52. PubMed ID: 22191530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ribosome Protection Proteins-"New" Players in the Global Arms Race with Antibiotic-Resistant Pathogens.
    Ero R; Yan XF; Gao YG
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Context-specific action of macrolide antibiotics on the eukaryotic ribosome.
    Svetlov MS; Koller TO; Meydan S; Shankar V; Klepacki D; Polacek N; Guydosh NR; Vázquez-Laslop N; Wilson DN; Mankin AS
    Nat Commun; 2021 May; 12(1):2803. PubMed ID: 33990576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ribosome protection by antibiotic resistance ATP-binding cassette protein.
    Su W; Kumar V; Ding Y; Ero R; Serra A; Lee BST; Wong ASW; Shi J; Sze SK; Yang L; Gao YG
    Proc Natl Acad Sci U S A; 2018 May; 115(20):5157-5162. PubMed ID: 29712846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Translational control of antibiotic resistance.
    Witzky A; Tollerson R; Ibba M
    Open Biol; 2019 Jul; 9(7):190051. PubMed ID: 31288624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 2-Guanidino-quinazolines as a novel class of translation inhibitors.
    Komarova Andreyanova ES; Osterman IA; Pletnev PI; Ivanenkov YA; Majouga AG; Bogdanov AA; Sergiev PV
    Biochimie; 2017 Feb; 133():45-55. PubMed ID: 28011211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. trans-Translation inhibitors bind to a novel site on the ribosome and clear Neisseria gonorrhoeae in vivo.
    Aron ZD; Mehrani A; Hoffer ED; Connolly KL; Srinivas P; Torhan MC; Alumasa JN; Cabrera M; Hosangadi D; Barbor JS; Cardinale SC; Kwasny SM; Morin LR; Butler MM; Opperman TJ; Bowlin TL; Jerse A; Stagg SM; Dunham CM; Keiler KC
    Nat Commun; 2021 Mar; 12(1):1799. PubMed ID: 33741965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Studies on the mechanism of translocation in ribosomes. V. Comparison of the effect of antibiotic inhibitors of ribosomes on "enzymatic" and "non-enzymatic" translation].
    Kostiashkina OE; Asatrian LS; Gavrilova LP; Spirin AS
    Mol Biol (Mosk); 1975; 9(5):775-82. PubMed ID: 765776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aminoglycoside and its derivatives as ligands to target the ribosome.
    Tok JB; Bi L
    Curr Top Med Chem; 2003; 3(9):1001-19. PubMed ID: 12678834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using sequence-specific oligonucleotides to inhibit bacterial rRNA.
    Trylska J; Thoduka SG; Dąbrowska Z
    ACS Chem Biol; 2013; 8(6):1101-9. PubMed ID: 23631412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Translation and protein synthesis: macrolides.
    Katz L; Ashley GW
    Chem Rev; 2005 Feb; 105(2):499-528. PubMed ID: 15700954
    [No Abstract]   [Full Text] [Related]  

  • 40. The other target for ribosomal antibiotics: inhibition of bacterial ribosomal subunit formation.
    Champney WS
    Infect Disord Drug Targets; 2006 Dec; 6(4):377-90. PubMed ID: 17168803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.